Medication info
Bonpiljeong 70 mg (Alendronate Sodium Hydrate)

Bonpiljeong 70 mg (Alendronate Sodium Hydrate)

Prescription medicationTabletOral
Ingredient · strength
Sodium Alendronate Hydrate›91.37mg / 1 tablet
Manufacturer / importer
Myungmoon Pharmaceutical Co., Ltd.
Appearance
White oval tablet
Packaging
4 tablets (4 tablets (Alu-Alu) X1)
Approval status
Active

MFDS item code 200803184 · Notified 2008.03.21 · Insurance code 649804050

Summary

Main use
Treatment of osteoporosis in postmenopausal women and men
Who takes it
Adults
Adult dose
○ Take 70 mg of alendronic acid once weekly in the morning with a sufficient amount of water at least 30 minutes before consuming any food, beverages, or other medicines (see Precautions). ○ Other beverages or food, including mineral water and barley tea, and medicines may reduce the absorption of this medicine (see Drug Interactions). Consuming food within 30 minutes after taking this medicine or at the same time may reduce its absorption into the body and decrease its efficacy. Take this medicine as soon as you get up in the morning and swallow it with a sufficient amount of water (170 ∼ 230 mL) to help it reach the stomach rapidly and reduce the possibility of esophageal irritation. Do not lie down for at least 30 minutes after taking this medicine and until after your first food intake. Do not take this medicine at bedtime or before getting up in the morning. Failure to follow these instructions may increase the risk of esophageal adverse reactions (see Warnings and Precautions). Patients whose dietary intake of calcium and vitamin D is insufficient should take supplements (see Precautions). ○ The optimal duration of treatment has not been established. The safety and efficacy of this medicine for the treatment of osteoporosis are based on 4 years of clinical data. The need for continued treatment should be reassessed regularly in all patients receiving bisphosphonates. In patients at low risk of fracture, discontinuation should be considered after 3 ∼ 5 years of treatment. Patients who discontinue treatment should be reassessed regularly for fracture risk. ○ If you miss a dose on the scheduled day, take 70 mg the next morning, then resume taking it on the originally scheduled day and continue taking it regularly once weekly thereafter. However, do not take 2 tablets on the same day.

Ingredients

Manufacturer
Myungmoon Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of osteoporosis in postmenopausal women and men

  • Osteoporosis
View approved original text

This medication is used for the treatment of osteoporosis that can occur in both postmenopausal women and men. Osteoporosis is a condition characterized by decreased bone density, which increases the risk of fractures. This medication helps strengthen bones and prevent fractures. Therefore, it is effective not only for the management of osteoporosis in postmenopausal women but also in men.

How to take

Adult dose

○ Take 70 mg of alendronic acid once weekly in the morning with a sufficient amount of water at least 30 minutes before consuming any food, beverages, or other medicines (see Precautions). ○ Other beverages or food, including mineral water and barley tea, and medicines may reduce the absorption of this medicine (see Drug Interactions). Consuming food within 30 minutes after taking this medicine or at the same time may reduce its absorption into the body and decrease its efficacy. Take this medicine as soon as you get up in the morning and swallow it with a sufficient amount of water (170 ∼ 230 mL) to help it reach the stomach rapidly and reduce the possibility of esophageal irritation. Do not lie down for at least 30 minutes after taking this medicine and until after your first food intake. Do not take this medicine at bedtime or before getting up in the morning. Failure to follow these instructions may increase the risk of esophageal adverse reactions (see Warnings and Precautions). Patients whose dietary intake of calcium and vitamin D is insufficient should take supplements (see Precautions). ○ The optimal duration of treatment has not been established. The safety and efficacy of this medicine for the treatment of osteoporosis are based on 4 years of clinical data. The need for continued treatment should be reassessed regularly in all patients receiving bisphosphonates. In patients at low risk of fracture, discontinuation should be considered after 3 ∼ 5 years of treatment. Patients who discontinue treatment should be reassessed regularly for fracture risk. ○ If you miss a dose on the scheduled day, take 70 mg the next morning, then resume taking it on the originally scheduled day and continue taking it regularly once weekly thereafter. However, do not take 2 tablets on the same day.

Precautions

This medication can irritate the gastric and esophageal mucosa, so caution should be exercised in patients with upper gastrointestinal diseases such as gastritis, esophagitis, esophageal ulcers, and esophageal erosion. After taking this medication, symptoms such as esophagitis, esophageal ulcers, and esophageal erosion may occur, and in rare cases, it can worsen to esophageal obstruction or perforation. If severe symptoms occur, discontinue use immediately and consult a doctor. This medication should be taken with a sufficient amount of water, and after ingestion, you should not lie down for at least 30 minutes but should sit or stand to reduce the risk of esophageal irritation. Patients with esophageal strictures or achalasia, those who cannot sit or stand upright for more than 30 minutes, patients allergic to this medication or its ingredients, those with hypocalcemia, severe renal failure, pregnant or nursing women, and patients with certain genetic metabolic disorders should not be administered this medication. During treatment with this medication, blood serum calcium levels should be monitored periodically, and supplements should be taken if calcium or vitamin D levels are low, along with maintaining weight-bearing exercises and a healthy lifestyle. While taking this medication, bone, muscle, and joint pain may occur, and in rare cases, severe pain may arise. Therefore, consult a doctor if symptoms are severe. A rare side effect of osteonecrosis of the jaw has been reported, and if dental treatment or tooth extraction is needed, a treatment plan should be discussed with a doctor, and oral hygiene should be maintained. Long-term use may increase the risk of fractures in specific areas, so if persistent bone pain occurs, you should see an orthopedic specialist. There may be interactions with calcium supplements, antacids, or other oral medications, so other medications should be taken at least 30 minutes apart after taking this medication. Pregnant or nursing women should not use this medication, and safety and efficacy in children and adolescents under 18 have not been established. Elderly individuals can use this medication, but caution is needed as some elderly patients may respond more sensitively. In cases of overdose, symptoms such as hypocalcemia and gastrointestinal disturbances may occur, and you should not induce vomiting; rather, seek medical attention immediately. This medication should be stored out of the reach of children and should not be transferred to another container.

Side effects

Hemorrhage, esophagitis, esophageal ulcer, esophageal erosion, esophageal obstruction, esophageal perforation, dysphagia, odynophagia, retrosternal pain, heartburn, abdominal pain, nausea, dyspepsia, constipation, diarrhea, flatulence, acid reflux, vomiting, abdominal distension, gastritis, gastric ulcer, musculoskeletal pain, muscle cramps, headache, dizziness, altered taste, rash, erythema, anastomotic ulcer, urticaria, angioedema, myalgia, fatigue, asthenia, fever, symptoms of hypocalcemia, peripheral edema, oropharyngeal ulcer, localized mandible necrosis, joint swelling, low-energy fractures of the femoral head and other bones, dizziness, pruritus, hair loss, skin and mucous membrane syndrome, toxic epidermal necrolysis, uveitis, scleritis, episcleritis, cholesteatoma of the external auditory canal

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to avoid exposure to air and moisture, and it should be stored at a temperature between 1 to 30 degrees Celsius, which is safe. Proper storage helps maintain the medication's effectiveness for a longer period.

Appearance and packaging

Appearance

White oval tablet

Package unit

4 tablets (4 tablets (Alu-Alu) X1)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.